Lintuzumab Uses, Dosage, Side Effects and more
Lintuzumab is under investigation in clinical trial NCT00016159 (Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia).
| Attribute | Details |
|---|---|
| Trade Name | Lintuzumab |
| Generic | Lintuzumab |
| Lintuzumab Other Names | Lintuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
